For the nine months ended Q3 FY2026, revenue was 1,431 million yen (Year-over-Year 2.5% increase), operating income was 109 million yen (YoY -22.8%), and quarterly net income was 59 million yen (YoY -24.9%), showing a slowdown. Meanwhile, revenue to medical corporations was 305 million yen (YoY 81.3% increase) with significant growth. Full-year FY2026 forecasts are unchanged; note that consolidated reporting will commence from FY2026 due to the acquisition of Orange Page.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7363","jir_company_name":"baby calendar Inc.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-11-13","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/7363-20261113-01.pdf","jir_short_summary":"For the nine months ended Q3 FY2026, revenue was 1,431 million yen (Year-over-Year 2.5% increase), operating income was 109 million yen (YoY -22.8%), and quarterly net income was 59 million yen (YoY -24.9%), showing a slowdown. Meanwhile, revenue to medical corporations was 305 million yen (YoY 81.3% increase) with significant growth. Full-year FY2026 forecasts are unchanged; note that consolidated reporting will commence from FY2026 due to the acquisition of Orange Page.","jir_summary":"### Overview of Results\nWhile cumulative revenue for the third quarter increased, operating income, ordinary income and net income trailed the prior year. The media business maintained a recovery trend in advertising revenue but was affected by the suspension of monetization on certain channels, resulting in a decrease versus the prior year. The business for medical corporations showed substantial growth in both revenue and segment profit driven by expanded new implementations. Full-year forecasts for FY2026 remain unchanged, and consolidated reporting is scheduled to begin from FY2026 due to the acquisition of Orange Page as a wholly owned subsidiary.\n\n### Outlook and Key Points\nThe transition to consolidated financial statements due to the acquisition of Orange Page is scheduled to begin in FY2026, and consolidated forecasts are currently under review. Although quarterly advertising revenue recovery continues, the financial summary notes uncertain elements that could affect forecasts and should be monitored as potential volatility factors. The medical corporation business is performing steadily and should be watched as a medium- to long-term growth driver.","jir_financial_highlights":"Revenue: 1,431,929 (Year-over-Year 2.5% increase)\nOperating Income: 109,629 (Year-over-Year -22.8% decrease)\nOrdinary Income: 104,907 (Year-over-Year -22.3% decrease)\nQuarterly Net Income: 59,345 (Year-over-Year -24.9% decrease)\nRevenue to Medical Corporations: 305,090 (Year-over-Year 81.3% increase)\nSegment Profit for Medical Corporations: 95,141 (Year-over-Year increase)","jir_category":"","jir_hashtags":"#babycalendarIR, #Earnings","jir_key_figures":"Revenue: 1,431,929 thousand yen (Year-over-Year 2.5% increase)\nOperating Income: 109,629 thousand yen (Year-over-Year -22.8% decrease)\nRevenue to Medical Corporations: 305,090 thousand yen (Year-over-Year 81.3% increase)","jir_meta_title":"baby calendar Inc. Q3 FY2026 Financial Summary - Key Points\uff5cNovember 13, 2026","jir_meta_description":"baby calendar Inc. reported Q3 revenue of 1,431 million yen and operating income of 109 million yen. Revenue to medical corporations surged, and consolidated reporting will begin from FY2026. See the IR financial summary for details.","jir_og_title":"Analysis of baby calendar Inc. Q3 FY2026 Financial Results\uff5cNovember 13, 2026","jir_og_description":"Q3 revenue was 1,431 million yen. Advertising revenue recovery continues, but operating profit declined. Medical corporation business posted significant growth. Consolidation to start from the December fiscal year.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Revenue Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Q1\\\",\\\"Q2\\\",\\\"Q3\\\",\\\"Q4\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Revenue\\\",\\\"data\\\":[1400, 1350, 1432, null]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Q1\\\",\\\"Q2\\\",\\\"Q3\\\",\\\"Q4\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[120, 150, 110, null]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Revenue Breakdown\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Media Business\\\",\\\"Medical Corporations Business\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Revenue\\\",\\\"data\\\":[1127,305]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"margin_analysis\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Margin Analysis\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Revenue\\\",\\\"Operating Income\\\",\\\"Ordinary Income\\\",\\\"Net Income\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Margin\\\",\\\"data\\\":[%],\\\"borderWidth\\\":2}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"guidance_comparison\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Guidance vs Actual Comparison\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Revenue\\\",\\\"Operating Income\\\",\\\"Net Income\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Full-year Guidance\\\",\\\"data\\\":[1838,111,70]},{\\\"label\\\":\\\"Actual\\\",\\\"data\\\":[1431,110,59]}]},\\\"options\\\":{}}\"}]","ir_related_company":61329,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-153145","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n